Definitive Healthcare reported Q4 2023 financial results, highlighting a 9% year-over-year increase in revenue to $65.9 million. The company's net loss was $13.4 million, while adjusted EBITDA reached $19.8 million, representing 30% of revenue.
Revenue increased by 9% year-over-year, reaching $65.9 million.
Net loss was $13.4 million, representing (20)% of revenue.
Adjusted Net Income was $10.6 million, compared to $10.3 million in Q4 2022.
Adjusted EBITDA was $19.8 million, or 30% of revenue.
Definitive Healthcare issued financial guidance including the effect of the acquisition of the Carevoyance product suite.
Analyze how earnings announcements historically affect stock price performance